A lawsuit filed in a Texas federal district court is aiming to limit Americans’ access to mifepristone, commonly referred to as the abortion pill. Anti-abortion advocates say the U.S. Food and Drug Administration (FDA) should rescind its approval of the medication until it can be adequately tested. “The FDA has one job, which is just to protect Americans from dangerous drugs,” said Denise Harle, senior counsel with the Alliance Defending Freedom, one of the conservative-leaning groups that brought the lawsuit. “We’re asking the court to remove that chemical drug regimen until and unless the FDA actually goes through the proper…

The Trump Administration has cut $216 million in funding for the Teen Pregnancy Prevention Program, administered by the Health and Human Services Department’s Office of Adolescent Health (OAH). OAH describes the program as “a national, evidence-based program that funds diverse organizations working to prevent teen pregnancy across the United States … with a focus on populations with the greatest need in order to reduce disparities in teen pregnancy and birth rates.” The cuts will affect more than 80 institutions around the country that are currently conducting multi-year research projects. The projects were awarded five-year grants in 2015 that will now end…